Table 2.
Maternal and neonatal outcomes according to glucose monitoring system
| Outcome | Total cohort (n = 186) | rtCGM (n = 92) | iCGM (n = 94) | p value |
|---|---|---|---|---|
| Pre-eclampsia/PIH | 34 (18) | 15 (16) | 19 (20) | 0.47 |
| Caesarean section | 87 (47) | 46 (50) | 41 (44) | 0.38 |
| Gestational age (weeks) | 38 (27–40) | 38 (27–40) | 38 (29–40) | 0.47 |
| Preterm birth (<37 weeks) | 52 (28) | 24 (26) | 28 (30) | 0.57 |
| Female infant | 87 (47) | 48 (52) | 39 (41) | 0.14 |
| Birthweight, g | 3823 ± 711 | 3812 ± 678 | 3834 ± 747 | 0.84 |
| LGA infant | 98 (53) | 48 (52) | 50 (53) | 0.89 |
| Macrosomia (>4500 g) | 30 (16) | 14 (15) | 16 (17) | 0.74 |
| 5 min Apgar score <7 | 6 (3) | 1 (1) | 5 (5) | _ |
| Shoulder dystocia | 5 (3) | 3 (3) | 2 (2) | _ |
| Neonatal hypoglycaemiaa | 45 (24) | 19 (21) | 26 (28) | 0.27 |
| NICU admission >24 h | 60 (32) | 27 (29) | 33 (35) | 0.40 |
| NCOb | 83 (45) | 37 (40) | 46 (49) | 0.23 |
Results are given as n (%), mean ± SD or median (range)
aDefined as plasma glucose < 2.6 mmol/l > 3 h after birth
bNeonatal composite including ≥ 1 of the following: macrosomia (> 4500 g), shoulder dystocia, neonatal hypoglycaemia or NICU admission > 24 h
Missing data were below 5% for all variables
PIH, pregnancy-induced hypertension